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Abstract
Purpose: Pluripotent cells residing in the periosteum, a bi-layered membrane enveloping all bones, exhibit a remarkable
regenerative capacity to fill in critical sized defects of the ovine femur within two weeks of treatment. Harnessing the
regenerative power of the periosteum appears to be limited only by the amount of healthy periosteum available. Here we
use a substitute periosteum, a delivery device cum implant, to test the hypothesis that directional delivery of endogenous
periosteal factors enhances bone defect healing.
Methods: Newly adapted surgical protocols were used to create critical sized, middiaphyseal femur defects in four groups of
five skeletally mature Swiss alpine sheep. Each group was treated using a periosteum substitute for the controlled addition
of periosteal factors including the presence of collagen in the periosteum (Group 1), periosteum derived cells (Group 2), and
autogenic periosteal strips (Group 3). Control group animals were treated with an isotropic elastomer membrane alone. We
hypothesized that periosteal substitute membranes incorporating the most periosteal factors would show superior defect
infilling compared to substitute membranes integrating fewer factors (i.e. Group 3.Group 2.Group 1.Control).
Results: Based on micro-computed tomography data, bone defects enveloped by substitute periosteum enabling
directional delivery of periosteal factors exhibit superior bony bridging compared to those sheathed with isotropic
membrane controls (Group 3.Group 2.Group 1, Control). Quantitative histological analysis shows significantly increased
de novo tissue generation with delivery of periosteal factors, compared to the substitute periosteum containing a collagen
membrane alone (Group 1) as well as compared to the isotropic control membrane. Greatest tissue generation and maximal
defect bridging was observed when autologous periosteal transplant strips were included in the periosteum substitute.
Conclusion: Periosteum-derived cells as well as other factors intrinsic to periosteum play a key role for infilling of critical
sized defects.
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Introduction
Critical sized defects do not heal spontaneously without
surgical intervention. Numerous surgical techniques have been
employed to treat these defects with limited success and a large
number of complications [1]. Distraction osteogenesis has
become a standard of care for the treatment of large diaphyseal
bone defects due to superior union rates achieved with it in
comparison with other surgical techniques [1–19]. Nonetheless,
distraction osteogenesis has several disadvantages including long
and labor-intensive treatment times, significant demands on
patient compliance, discomfort, and high rates of complications
with associated requirements for multiple surgical procedures
following the index procedure. In addition, the technique
requires significant technical expertise, which limits the number
of orthopaedic surgeons with the training and experience
necessary to perform the procedure. Even when implemented
by surgeons with significant expertise, the relatively high rate of
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28702complications and subsequent need for reoperations associated
with the technique persists [11,13,17].
These and other factors provided the impetus for the
development of a one stage bone transport procedure that
harnesses the regenerative power of the periosteum to fill in
critical sized defects without the need for adjuvant bone graft
(Fig. 1) [20–22]. Histology and quantitative micro-computed
tomography (m-CT) studies indicate that the cells and blood supply
within the periosteum are key to success of the one stage procedure
[21,22]. Interestingly, filling of the periosteum enveloped defect
with autologous bone graft from the iliac crest retards the infilling
of the defect due to the need for prior osteoclastic resorption [22].
Based on experimental and several clinical cases, implementation
of the one stage bone transport procedure appears to be limited
only by the amount of healthy periosteum available [20–22]. The
current study addresses that limitation.
In the current study we implement a newly developed surgical
reconstruction membrane as a substitute for the periosteum to
treat a critical sized (2.54 cm) defect in a previously developed
adult ovine femur model with intramedullary nailing for
mechanical stabilization [21]. Our goal was to design a periosteum
substitute that mimics the structure-function properties inherent to
native periosteum. As a bi-layered membrane, native periosteum
exhibits anisotropic, composite structure conferring unique
functional properties [23]. The periosteum’s outer layer comprises
mostly collagens, aligned with the longitudinal axis, and elastin;
this outer layer is hypothesized to control bone shape/length
during growth [24], to contribute to bone toughness, and to limit
displacement of fracture fragments to stabilize bones after bone
failure [25]. The cambium, or periosteum’s innermost layer,
comprises mostly cells that appose the underlying bone [26]. The
progenitor cells within the inner cambial layer are responsible for
continual periosteal bone apposition during life and confer
regenerative properties to the periosteum [21,22,27–30].
Hence, we designed our periosteum substitute to serve as a
delivery device cum implant exhibiting a modular design with
pockets to allow for directional (outsideRin), spatial (via anterior,
posterior, medial and lateral pockets), and temporal control of
factor delivery (Fig. 2A). The periosteum substitute design per se
mimics the structure of native periosteum, the outer layer of which
is made up of the structural proteins elastin and collagen. In this
study, we used the periosteum substitute for the controlled
addition of periosteal factors including the presence of collagen,
the predominant structural protein of the extracellular matrix that
is present in the outer sheath of the periosteum [26] (Group 1,
Fig. 2B), cells residing within the periosteum (Group 2, Fig. 2C),
and autologous periosteal strips (Group 3, Fig. 2D). Animals of
the Control group were treated with an isotropic membrane alone.
We hypothesized that periosteal substitute membranes incorpo-
rating the most periosteal factors would show superior defect
infilling compared to substitute membranes integrating fewer
factors (i.e. Group 3.Group 2.Group 1.Control).
Methods
Ethics Statement
All work was conducted according to relevant national and
international guidelines; full details of the study were approved by
the Amt fu ¨r Lebensmittelsicherheit und Tiergesundheit Graubu ¨n-
den (Institutional Review Board of the Canton of Grisons,
Switzerland), Tierversuchsbewilligung (Animal Experiment Per-
mission) No. 15/2008.
Overview
Previously described surgical protocols were used to create
critical sized, middiaphyseal femur defects [21], first in one short
term (3 week) pilot group treated with periosteum substitute
implants incorporating collagen membranes (Group 1). Thereaf-
ter, we treated four groups of five skeletally mature Swiss alpine
sheep for sixteen weeks, a period over which defects surrounded by
periosteum in situ heal completely and untreated defects do not
heal (providing proof of critical size) [21,22].
Each group was treated using a substitute periosteal membrane
designed and manufactured according to our protocols [31,32] to
deliver specific factors to the defect zone (Fig. 2, Table 1). The
substitute periosteum implants comprised combinations of FDA-
approved materials and/or autologous materials including perios-
teum derived cells and periosteal strips from the bone removed to
create the defect. The FDA approved materials used to make the
implants included medical grade silicone elastomer sheeting,
absorbable collagen membrane derived from bovine achilles
tendon, and nonresorbable sutures (Fig. 2). The periosteum
substitutes were designed to be easily manufactured, modular (the
pocket design allows for substitution as well as precise localization
and timing for release of specific factors or combinations of
factors), fully sterilizable with other surgical armamentaria, and
easy to use by surgeons with varying degrees of expertise.
Figure 1. The one-stage bone-transport procedure [20–22]
harnesses the regenerative potential of the periosteum and
cells therein, e.g. for treatment of a critical sized long bone
defect after tumor resection. (a) The tumor is first identified and (b)
then resected in toto, leaving a critical sized defect. The periosteum is
scored (dashed line, b) and (c) gently peeled back off the proximal
bone, leaving denuded bone below. (d) The denuded bone is
osteotomized and transported distally to fill the defect zone. It is
docked to the distal, healthy femur using ligament sutures. A limiting
factor in implementation of this technique is the availability of
periosteum in areas easily accessible to the surgical site. This is
particularly problematic in high impact trauma injuries such as blast
wounds or high speed sports or traffic injuries. Images used with
permission [21].
doi:10.1371/journal.pone.0028702.g001
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perforated with a gradient of holes along its entire length, with the
highest concentration of holes near the center of the defect region,
decreasing toward the edges that are sutured to the periosteum of
healthy bone proximal and distal to the defect zone. The pattern
of holes was achieved using a double (parallel) sewing machine
needle (without thread) and setting the sewing machine stitch
length to achieve equidistance at the center of the defect between
rows of double holes. The inner membrane was then sewn, using
the suture material, to the outer membrane, which was devoid of
perforations, creating a long sleeve (3.5610 cm) with four, 2 cm
wide pockets (Fig. 2A). The whole construct was then placed on
surgical dressing gauze and encapsulated within a sterilization
sleeve for steam sterilization in an autoclave with other surgical
instruments.
Shortly before surgical implantation (in the sterile surgical
operating theatre), the substitute periosteum implant was removed
from the sterile packaging and experimental (periosteal) factors
were placed in the implant pockets (collagen membrane - Group 1,
collagen membrane seeded with autogenous periosteum derived
cells - Group 2, or strips of autogenous periosteum transplants
from bone removed to create defect - Group 3, Table 1). The
implant was then sutured to periosteum lifted along the edge of the
remaining bone proximal and distal to the defect (Fig. 2D, Fig. 3).
The control group was treated with a simple, isotropic silicone
elastomer membrane (without flow directing architecture) around
the critical sized defect. Group 1 was treated with a membrane
and collagen sheets, incorporating flow directing architecture,
which allows for directional transport, i.e. from the proximal and
distal edges axially toward the center, and from the membrane
Figure 2. A periosteal substitute, novel directed delivery
device cum implant was developed and implemented to mimic
structure-function relationships intrinisic to the periosteum
and to enable vectorial delivery, i.e. control of delivery
direction and magnitude or concentration, of periosteal
factors. In the current study we tested the efficacy of directional
delivery of periosteal factors to enhance defect healing. (A) The implant
comprises an outer elastomeric membrane (FDA approved material), an
inner elastomeric membrane with a gradient of perforations of highest
concentration furthest from the proximal and distal edges of the defect
zone. The layers are sewn together with suture material, creating four
pockets into which periosteal factors can be tucked. (B) Collagen
membranes (FDA approved) were cut and tucked into the pockets of
Group 1 implants. (c) Cells were isolated from periosteum of the bone
removed to create the defect, seeded on the collagen membranes (FDA
approved), and tucked into the pockets of Group 2 implants. (D) Strips
of periosteum were resected from bone removed to create the defect
and tucked into the pockets of Group 3 implants. Bony bridging of
defects sheathed by each respective periosteum substitute was
compared between groups and with a Control group implementing
an isotropic, simple elastomeric membrane (FDA approved). (E) The
periosteum substitute implant was then sutured to the proximal and
distal edges of periosteum lifted along the edges of the defect and
sutured close along the longitudinal axis of the lateral aspect. Refer to
Fig. 3 for intraoperative photo.
doi:10.1371/journal.pone.0028702.g002
Table 1. Defect bridging was scaled to assess objectively
defect bridging without the ability to measure volume of
bone generated quantitatively due to the presence of the
intramedullary nail.
GROUPS 0–25% 25–50% 50–75% 75–100%
EMPTY 7/7
Control
Membrane
4/5 1/5
1: Membrane + Collagen 5/5
2: Membrane + Collagen + Cells 1/5 2/5 1/5 1/5
3: Membrane + Periosteal
Strips
2/5 1/5 2/5
INTACT PERIOSTEUM 7/7
For comparative purposes, images from a previous study using the same animal
model were assessed using the same scaling method, comparing to the empty
defect zone (see Fig. 7A), which was left without treatment and which never
healed, indicative of a true critical sized defect [21]. Also, the use of intact
periosteum with adherent cortical bone chips on the inner surface, from the
previous study, is compared as the ‘‘best observed outcome’’ which provides
target specifications for the periosteum substitute implant [21].
doi:10.1371/journal.pone.0028702.t001
Figure 3. Intraoperative photo showing a periosteal substitute
in situ, enveloping a critical sized defect in the middiaphysis of
the ovine femur.
doi:10.1371/journal.pone.0028702.g003
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membrane as in Group 1, but the collagen sheet within the
membrane was pre-seeded with cells isolated from periosteum of
the autologous defect bone and incubated at 37uC overnight. After
careful aspiration and washing, the cell-seeded membrane was
then placed into the four pockets of the substitute periosteum.
Finally, Group 3 received the membrane in combination with
autologous periosteal transplant strips (isolated from the bone
removed to create the defect zone) in place of the collagen sheets.
Animals were euthanized at 3 (pilot group) and 16 weeks after
surgery. Femoral tissue blocks including surrounding musculature
were scanned with the intramedullary (IM) nail in situ using high
resolution m-CT to determine efficacy of the periosteal substitutes
for defect bridging. Due to the retention of the steel IM nail (which
can cause imaging artifacts due to beam hardening), it was not
possible to obtain volumetric data from the m-CT images. For this
reason, bridging of the defect was ranked, by a blinded observer,
on a quartile scale (Table 1, 0–25%, 25–50%, 50–75%, 75–
100%), indicating degree of defect coverage for each treated
sample in each experimental group.
Finally, quantitative histomorphometry was carried out to
measure bone generation in the defect zone and to compare the
mean bone regenerated between groups.
Detailed Methods
Sheep and surgical procedures. The experimental protocol
was carried out, using skeletally mature Swiss alpine sheep (n=5
per group, 3 experimental and one control group), at the AO
Research Institute in Davos, Switzerland, with the approval of the
animal care and use commission of the Canton of Grisons.
All surgeries were performed by URK. Surgery was performed
with sheep in the right lateral position. After general anaesthesia
with intubation and spinal anaesthesia, the left hindlimb was
shaved and prepped with Hibiscrub solution and draped. The
right hind limb was strapped with a belt extending around the
operating table and the abdomen. The sheep was then transported
into the operating room and the left hind limb was prepped and
draped in the usual sterile fashion. A lateral parapatellar approach
was performed to enter the knee joint to prepare for retrograde IM
nailing. The patella was dislocated medially. A 4 mm entry hole
was then placed in the midline of the trochlea, approximately
8 mm anterior to the intracondylar notch. Sequential reaming of
the intramedullary canal was performed with increasing sized
cutting reamers, starting at 7 mm, going up to 14 mm. The
flexible Synthes reamer system was then used to ream 15 mm, up
to 16 mm, in 0.5 mm increments.
Attention was then turned lateral to the femur and a second,
approximately 12.5 cm incision was made lateral over the femur.
The vastus lateralis fasciae and the intramuscular plane were
developed to expose the lateral aspect of the femur. Meticulous
hemostasis and ligation of larger vessels was performed, distal third
of the femur. The vastus lateralis was then detached from the bone
with a scalpel to expose the distal femur with a 1–2 mm layer of
muscle attached. A 2.54 cm critical sized defect was then created
8 cm proximal to the knee joint line with an oscillating saw using
small amplitude and preserving the soft tissue with rounded
custom retractors.
The periosteum was then lifted circumferentially, approximately
5 mm from the proximal and distal defect/osteotomy edges, with
a periosteal elevator. Thereafter, the intramedullary nail was
inserted retrograde and care was taken to maintain the 2.5 cm
critical defect size. Two proximal and two distal 4.9 mm
interlocking bolts were then placed.
The 3.5 cm periosteum substitute membrane was then
introduced around the defect using a custom S-shaped retractor
to maintain space medial to the femur-nail. The membrane was
placed from anterolateral side and brought posterior around the
defect. The membrane was designed to overlap 0.5 cm distal and
proximal to the defect. In the case of the experimental membrane,
the outer layer overlapped the elevated periosteum by 5 mm and
the inner layer was placed so that the periosteum was sandwiched
between and sutured carefully in place with Dermalon 4.0 sutures,
while applying inner and outer rotation of the hind limb as needed
to reach regions behind the IM nail. In the case of the simple
control membrane, the membrane was placed overlapping the
elevated periosteum by 5 mm and sutured in place. The edges of
the membrane were connected laterally using Dermalon 4.0
sutures and trimmed to fit the circumference of the defect.
The knee and lateral femoral incisions were then closed in layers
with no suction tube trains, using vicryl #1 for fascia, 2.0 for
subcutaneous, and Moncryl 3.0 for subcuticular running sutures.
Periosteum substitute implant manufacture. Substitute
periosteal membrane were designed and manufactured by MKT
as sterilizable, modular units to deliver specific factors to the defect
zone. Delivery devices (modular implant with pockets) were
manufactured from FDA approved materials, including medical
grade silicone sheeting (Bioplexus, 0.0050 thick medium duro-
meter silicone elastomer, Ventura, CA), and nonresorbable sutures
(Dermalon 4-0, monofilament nylon, Syneture, Covidien Surgical,
Dublin, Ireland). Absorbable collagen membranes (BiomendH,
derived from bovine achilles tendon, Zimmer Dental, Carlsbad,
CA), designed for periodontal use, were cut to size and placed in
implant pockets in Groups 1 (collagen membrane alone) and 2
(collagen membrane seeded with cells isolated from autologous
periosteum). Autologous periosteal strips were placed in the
pockets of implants from Group 3, retaining the anatomic orien-
tation of the inner and outer surfaces. Cut to size but otherwise
unaltered, isotropic medical grade silicone sheets were used in the
control group. Bone growth within implants incorporating increas-
ing numbers of periosteal factors were compared with control
implants as well as with the baseline critical sized defect control
(untreated) and ‘‘gold standard’’ in situ periosteum treated defects
studied previously [21].
Cell culture methods - isolation and proliferation of
periosteum derived cells. Cell culture was carried out by HC.
Ovine periosteum explants resected from the bone removed to
create the defect were immediately placed in TBSS with 1%
Penicillin/Streptomycin (P/S). The explants were then minced
and placed in spinner flasks with high glucose DMEM (GIBCO,
Grand Island, NY) with 1% P/S and 0.3% Collagenase II
(Worthington Biochemical Corporation, Lakewood, NJ). This was
incubated for 3 hours in a 37uC incubator in 95% humidified air
and 5% CO2. The cells were filtered through a 40 mm vacuum
filter to remove fibrous tissue, centrifuged to remove the
collagenase solution, and resuspended in high glucose DMEM
with 10% FBS and 1% P/S. The cells were then seeded on precut
collagen membranes, which were sized to fit into the periosteal
implant pockets. The seeded membranes were then incubated
overnight at 37uC, in 95% humidified air with 5% CO2. The next
morning, after careful aspiration and rinsing in TBSS to remove
any cell culture chemicals, the seeded membranes were then
placed into the four pockets of the substitute periosteum implant,
under sterile conditions, in the surgical theater.
Prior to the surgical study we characterized growth rates of the
ovine periosteum derived cells. Adherent periosteum derived cells
were plated at 34,000 cells/cm
2 high sets of 8 in 96-well plates in
high glucose DMEM with 10% FBS and 1% P/S. Cell culture
Directional Delivery of Periosteal Factors
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for 7 days using WST-1 reagent (Roche Applied Science,
Indianapolis, IN) and incubated for 4 hours before measuring
absorbance.
Undecalcified histological preparation and measure-
ments of tissue generation. Histological sectioning and
analysis was carried out by SM and MKT. Following resection
and m-CT imaging, the femur and surrounding tissue were fixed
and embedded in poly(methyl methacrylate) (PMMA) for
undecalcified histology processing. A diamond wire saw was
used to produce three transverse sections through the tissue block
with intramedullary nail in situ; sections were taken at intervals of
approximately 6.5 mm to span the entire defect (Well Precision
Diamond Wire Saw 6234, Norcross, GA), and polished with a
variable speed Grinder-Polisher (Buehler EcoMet 4000, Lake
Bluff, IL). Both sides of each section were imaged, and full collages
of the cross-sections were created first, at 1.66 magnification to
establish a qualitative perspective on de novo bone generation and
healing trends between and across groups. Thereafter, cut surfaces
were stained with Giemsa and Eosin to quantify new tissue area
and distribution. The stain colors cell nuclei and connective tissue
dark blue, and mineralized tissue (bone) pink. Collages were made
of the proximal and distal side of all slices at 56 magnification
using an inverted epifluorescent microscope with automated,
computerized stage, (Leica DMIRE2, Wetzlar, Germany) and
using broad spectrum UV excitation to quantify de novo bone
generation and compare areas of new bone generated between
groups. Whole collages were processed using a custom designed
algorithm to identify and segment out mineralized (pink) and
cartilage (blue) tissue (Adobe Photoshop CS5, Adobe Systems
Incorporated, San Jose, CA). Thereafter, total areas of regenerates
for mineralized and cartilage tissue were calculated using a pixel-
to-area scaling factor (Image J version 10.2, NIH, Bethesda, MD).
To summarize the sample size for histological measures, three
sections were made through the mid-diaphyseal region of each
defect site, resulting in a total of six surfaces (both proximal and
distal) for each animal. With five animals in each group, this
resulted in a total of 30 high-resolution collages for each group
(Control, Group 1, Group 2 and Group 3), i.e. 120 collages in
total. Three collages were excluded because due to their near
proximity to the proximal or distal bone outside of the defect zone.
This resulted in an n$27 collages for all groups.
Results
Histomorphometric and m-CT data showed that membranes
incorporating periosteal factors significantly improved bone
generation in the critical sized defect compared to isotropic,
unstructured control membranes made of the same material
(Group 3.Group 2.Control, Table 1, Fig. 4, Fig. 5, Fig. S1,
S2, S3, S4). Bone generation in defects treated with isotropic
control membranes appeared to emanate from the proximal and
distal periosteal edges of the defect zone, tapering along the surface
of the intramedullary nail, from the intact bone toward the center
of the defect (Fig. S1); more new bone was observed in the
proximal half of the defect than the distal half and limited contact
was observed between the two areas of bone ingression. In
addition, limited proliferative woven bone was observed to radiate
inward from the isotropic membrane in only one specimen treated
with the isotropic control membrane (9047, Fig. S1).
At three weeks after treatment with periosteum substitute
implants incorporating collagen sheets (Group 1), intramembra-
nous, woven bone was observed emanating from the implant
toward the intramedullary nail in four of five defects studied
(Fig. 4, Fig. S2A). At three weeks after surgery, almost no
ingression of bone was observed from the intact periosteum of the
proximal and distal edges. The intramembranous bone observed
at three weeks was no longer evident in m-CT images at sixteen
weeks (Fig. S2B). In fact, at 16 weeks, Group 1 did not show
evidence of improved defect filling compared to the isotropic
control membrane, and the best case of the Control membrane
showed more infilling than the best case of the implants
incorporating collagen sheets alone. Furthermore, in contrast to
the control group, less ingression of bone was observed from the
proximal and distal edges of the defect. Bone that did ingress
proximally and distally appeared to exhibit less tapering toward
the intramedullary nail than in the Control group.
Figure 4. High resolution micro-computed tomography (m-CT)
of bone regenerate in Group 1 at 3 weeks and in all groups at
16 weeks after surgery. The intramedullary nail is present along the
longitudinal axis of all specimens. Each group comprised five sheep and
the sample images showing the least and most amount of new bone
are depicted for each group.
doi:10.1371/journal.pone.0028702.g004
Figure 5. Mean area of de novo bone regenerate in defect zone,
measured in histological sections through the defect zone.
Error bars represent standard error of the mean. Statistical significance
of differences between groups was tested using the Mann-Whitney
(Wilcoxon) test, with significance defined as p,0.05. p=0.0003,
p=0.0459, p=0.037.
doi:10.1371/journal.pone.0028702.g005
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(Group 2) within the periosteum substitute implant resulted in
significantly increased bone generation (Fig. 5, Fig. 6) and defect
bridging (Fig. 4, Fig. S3) compared to the isotropic control
membrane (Control) as well as compared to the periosteum
substitute with collagen sheets alone (Group 1). In contrast to both
the Control and Group 1 at 16 weeks, woven intramembranous
bone was evident in m-CT images from Group 2 at 16 weeks. In
addition, bone infilling appeared to have ingressed from the
proximal and distal edges of the defect, in nearest proximity to
healthy bone (with a tendency toward more bone in the proximal
than the distal half of the defect). In one specimen exhibiting the
most robust infilling/healing response of all in Group 2, the
inwardly radiating intramembranous bone also coalesced most
with proximally and distally ingressing bone, compared to other
specimens within the group (9046, Fig. S3).
Maximal bone infilling of the defect was observed in Group 3,
where autologous strips of periosteum were tucked into the pockets
of the modular periosteum substitute (Fig. 4, Fig. 5, Fig. 6, Fig.
S4). Two specimens exhibited coalescence of intramembranous
bone emanating from the membrane and bone ingressing from the
proximal and distal edges of the defect (9049, 9050, Fig. S4). Two
specimens exhibited a weaker intramembranous proliferative bone
response and ingression from the proximal, respectively distal,
edges (9048, 9051, Fig. S4) and one exhibited an intermediate
response (9052, Fig. S4).
Periosteum-derived cells proliferate exponentially during the
first seven days of seeding; linear regression gives the following
equation to predict cell number (y) as a function of days (x):
y~0:0045e1:1382x
Although the cell proliferation studies could not be conducted on
the collagen membrane due to the colorimetric measurements
needed for the proliferation assay, proliferation data shows that the
isolated cells are viable and proliferate steadily over the course of 7
days (Fig. 7).
Discussion
The current set of experiments indicate a key role for directional
delivery of periosteum-derived cells as well as other factors
intrinsic to periosteal transplants for infilling of critical sized
defects. Based on quantitive histomorphometry measurements as
well as micro-computed tomography data, bone defects enveloped
by substitute periosteum enabling directional delivery of periosteal
factors show significantly more bone generation as well as superior
bony bridging compared to those sheathed with isotropic
elastomer membrane controls. Maximal bridging was observed
when autologous periosteal transplant strips were included in the
periosteum substitute, followed by the group in which the
periosteum substitute delivered cells (derived from the periosteum),
radially, to the defect. Whereas the periosteum substitute
incorporating collagen membranes showed evidence for woven
bone generation, radially inward from the inner surface of the
implant, at three weeks after surgery, the radial woven bone
generation was not evident at sixteen weeks after surgery. Similar
to the isotropic control membrane, bone generation in the defect
zone at sixteen weeks after surgery occurred mainly via bone
ingression from proximal and distal edges of intact bone and
periosteum.
To place the results of the current study in context with our
previous work on treatment of criticial sized bone defects in the
same ovine model, we compared our current results with the those
of the baseline, untreated control as well as those of the ‘‘best
outcomes group’’ where the periosteum (with adherent cortical
bone on its inner surface) was left in situ around the defect (Fig. 7)
[21]. Due to the necessity to retain the intramedullary nail in the
femoral blocks of the current study, m-CT observations were
compared using a defect coverage scale. Thereafter we used
histomorphometric measures to compare quantitatively bone
Figure 6. Histological cross-sections for Giemsa and eosin-stained specimens showing representative areas of tissue regeneration
for each control and experimental group. (A) Stained and unprocessed specimen for the Control Group. (B) Stained and unprocessed specimen
for Group 1 incorporating collagen sheets. (C) Stained and unprocessed specimen for Group 2 incorporating periosteum derived cells seeded on
collagen sheets. (D) Stained and unprocessed specimen for Group 3 incorporating periosteal strips. (E) Segmented image from Group 3 (D)
highlighting mineralized tissue. (F) Demonstration of collage resolution, as shown in a single field-of-view (acquired from D). Scale bar for (A–E)i s
5 mm.
doi:10.1371/journal.pone.0028702.g006
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baseline control specimens were left empty; the lack of infilling and
bridging of the defect in all five specimens of this group provided
evidence for the defect’s critical size (Fig. 8A). Both the Control
group and Group 1 of the current study showed similar results,
with no bridging of the defect at 16 weeks after surgery. Thus,
neither implementation of the isotropic control membrane nor use
of the directional delivery membrane incorporating a collagen
sheet showed improvement in healing compared to the untreated
defect of the previous study. In contrast, Groups 2 and 3 of the
current study, which implemented the directional delivery
membrane in conjunction with periosteum-derived cells seeded
on the collagen sheet and strips of endogenous periosteum,
respectively, showed superior defect bridging and bone generation
in the defect zone compared to the untreated control of the
previous study. Accounting for all five specimens of each respective
group, healing was not as robust as that observed in the best
outcomes group of the previous study, where five of five defects
completely bridged (Fig. 8B) [21].
Given our explicit goal to mimic structure-function relationships
in the design of our periosteum substitute membrane, we were
surprised that inclusion of collagen sheets within the elastomeric
modular pockets showed no significant improvement in bone
generated within or bridging of the defect zone, compared to
isotropic membrane controls. At 16 weeks after surgery, previous
studies showed all critical sized defects to have healed completely
when surrounded by periosteum in situ [21]. Hence, based on
quantitative histomorphometric and qualitative m-CT data of the
current study, it appears the delivery of cells (seeded on collagen
sheets), or in combination with periosteum intrinsic factors,
provides a much more potent stimulus for tissue building than
delivery of collagen alone. Using this previously tested ovine defect
model with mechanical stabilization via a solid intramedullary
nail, the medullary niche and its resident, multipotent marrow
stromal cells are removed at the time of surgery. In native
periosteum, collagen and elastin form the outer, fibrous sheath,
encompassing the cambium (cellular) layer. When left in situ
around the defect, periosteum derived cells egress from the
cambium layer, inwards, to fill the defect with intramembranous
bone [21,22]. Of particular note, proliferation of periosteum
derived cells cultured on tissue culture styrene does not appear to
be contact inhibited, in contrast to other pluripotent cell lines [33].
Surprisingly little reference data exists with regard to character-
ization of periosteum derived multipotent cells in sheep, likely due
to the paucity of ovine surface markers (for FACS) or rtPCR
primers. In future studies it will be interesting to better mimic
molecular and cellular interactions to further functionalize the
periosteum substitute membrane.
From a clinical perspective, it would be expected that, in
surgical cases where insufficient periosteum is available to suture in
situ around tissue defects, use of the directional delivery implant in
conjunction with periosteum strips harvested from other areas
would provide a superior alternative to treatment with a simple
isotropic membrane sleeve. However, harvesting of periosteum
strips from elsewhere (e.g. proximal or distal to the area of tumor
resection or trauma) was not tested directly in the current study
and potentially could be associated with other complications when
implemented in patients. In the current study, periosteal strips
were resected from the bone to create the defect. Inclusion of
autologous periosteal strips would be expected to yield superior
results to inclusion of autologous periosteum-derived cells for
similar reasons, given the necessity of harvesting tissue and
subjecting the patient to a two stage procedure in order to harvest
and proliferate autologous cells on collagen membranes for
implantation in the directional delivery device. However, another
potential scenario would be to pre-seed collagen membranes with
pluripotent cells from a stem cell bank (e.g. [34,35]) prior to surgery
and then to incorporate the pre-seeded collagen sheets into the
directional delivery membrane at the time of surgery. This clinical
scenario would not only avoid the necessity of a two stage
procedure, but it would also not involve additional harvesting of
tissue (and potential additional complications associated with more
extensive surgical approaches) from the patient.
The current study implicates different spatiotemporal patterns
of bone formation via bone induction and bone conduction that
are modulated differently, depending on the surgical membrane
used. Whereas use of the directional delivery membrane appeared
to enable (rapid) early bone induction, radially inward from the
implant to the surface of the intramedullary nail, both the isotropic
and directional delivery membranes appeared to serve as an
osteoconductive sleeve as well, allowing for ingression of bone
from the proximal and distal edges of the defect, axially into the
defect zone. Albrektsson and Johansson differentiate osteoinduction,
‘‘the recruitment of immature cells and stimulation of these cells to
develop into preosteoblasts’’, from osteoconduction or surface
mediated bone growth [36]. Albrektsson and Johansson’s
Figure 8. High resolution micro-computed tomograph (m-CT)
images of healing 16 weeks after critical sized defect from the
previous study [21] (used with permission). (A) Baseline,
untreated control defect, confirming critical size of defects (does not
heal without treatment). Defect is completely healed in experimental
groups, e.g. (B) including group treated with periosteum, left in situ
with small cortical bone chips adherent to inner surface, around defect.
doi:10.1371/journal.pone.0028702.g008
Figure 7. Proliferation of seeded cells derived from ovine
periosteum. Error bars depict standard deviations.
doi:10.1371/journal.pone.0028702.g007
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duction via demineralized bone which initiates a biological
cascade resulting in endochondral ossification [37,38]. In the
current and previous studies, we describe the observed early,
woven bone proliferation as intramembranous rather than
endochondral [21,22,39], which better fits with Albrektsson and
Johansson’s definition. Taken one step further, we consider the
relative barrier properties of the membrane sleeve, in conjunction
with the impermeable surface of the intramedullary nail, to
provide a conduit that guides bone regeneration inwards radially,
similar (but in an opposite direction) to that suggested by
Gogolewski and colleagues [40]. Finally, a gradient of cells and
osteogenic factors is expected to develop between the inner surface
of the directional delivery membrane and the outer surface of the
IM nail, as well as between the edges and center of the defect zone;
cellular and biochemical gradients can further facilitate osteogen-
esis via osteoinduction and osteoconduction.
Histomorphological studies are underway to elucidate quanti-
tatively the time course of defect infilling via osteoinductive and
osteoconductive mechanisms. In the previous study, in groups
where periosteum, with small cortical bone chips adherent to the
inner surface, was left in situ around critical sized defects, rapid
proliferative woven bone was shown to infill the defect zone within
two weeks of surgery (as evidenced by fluorochrome labeling
during this time period) [21,22]. In that study, by sixteen weeks
after surgery, bone consolidated and its density and volume were
shown to be highly modulated by the loading history to which the
bone generated within the defect zone was subjected. Namely, in
areas along the bone axis most able to resist bending loads (along
the major centroidal axis), regenerate bone volume was higher and
regenerate bone density was lower than in areas along the bone
axis least able to resist bending (along the minor centroidal axis).
Furthermore, at the conclusion of the previous study, it was
impossible to assess wither bone induction or conduction had
played a more important role in healing, although the rapid
proliferative woven bone laid down in defects not packed with
morcellized bone graft appeared to favor a more rapid maturation
and remodeling of regenerate bone in the sixteen weeks of the
experimental study [21,22]. Of note, in the current study, the axial
ingression (osteoconduction) was more apparent in the proximal
half of the defect and was observed in the specimens examined at
16 weeks after surgery but not in those examined 3 weeks after
surgery (where osteoinduction was observed radially from the
implant toward the IM nail surface). An ongoing quantitative
histomorphological analysis of the specimens from the current
study should allow us to elucidate the spatiotemporal mechanisms
of bone generation occurring radially via periosteum derived cells
and axially via bone and periosteum of the proximal and distal
bone segments.
Previously published studies have underscored the need to
engineer periosteum substitutes [41] but have met with limited
success [42,43] in bridging critical sized defects and few have been
tested in large animal models where scale up of cell mediated tissue
generation is expected to be a major limitation. The approach
employed in the current study capitalizes on osteoinductive and
osteoconductive properties of periosteum substitutes, while
providing a means for directional delivery of cells and osteoinduc-
tive factors inherent to the periosteum as well as modulation of the
concentration of factors through tuning of the pore gradient on the
inner membrane surface. In effect, this allows for vectorial delivery
(a vector being defined by its magnitude and direction) of cells and
osteoinductive factors, filling in the defect from the outside in,
much like the mechanism by which osteoblasts infill resorption
cavities during bone remodeling [32,44].
There are several limitations inherent to the design, as well as to
financial constraints, associated with in vivo studies in large animal
models. First and foremost, we decided to retain the custom,
stainlesssteelIMnailinthe femoraltissueblocksattheconclusionof
the study in order to retain the precise spatial organization of the
biological samples. This was not necessary in our previous study
using periosteal sleeves around the defect, because all defects were
bridged and thus mechanically stable at the conclusion of the study.
Retention of the nail had a further implication of not allowing for
quantitative m-CT analysis due to beam hardening and due to
artifacts in imaging attributable to the presence of metallic implants
[45]. However, histomorphometric study of femoral blocks that are
fixed, embedded in PMMA, and sectioned serially in toto allowed for
quantitation of tissue generation and comparison between groups.
Ongoing histological analysis will allow for maximally precise
reconstruction of spatial and temporal (though analysis of chelating
fluorochromesadministeredatdefined timepointsinthestudy)bone
apposition in the sixteen weeks after surgery. Furthermore, given
unlimited resources, it would have been desirable to include more
experimental groups in the study to better elucidate effects of
independent variables. Nonetheless, the current study provides a
foundation that will help us to prioritize follow on studies, including
in silico (virtual) models that allow for prediction of outcomes
through variation of model parameters [46].
In trauma patients, as well as in surgical reconstruction patients,
the amount of remaining healthy periosteum represents a limit to
the use of the endogenous engineering approach demonstrated to
bridge critical sized defects in the ovine femur (one-stage bone-
transport procedure) [21,22]. The current studies, implementing
the newly developed periosteal substitutes, augmented through
addition of periosteal transplant from other bone sites, test the use
of the technology as a delivery vehicle for the patient’s endogenous
bone healing factors, expanding the indications for surgical
reconstruction sheets in treatment of long bone defects. In
addition, the periosteal substitutes, enhanced through seeding
with auto- or allogenic stem cells, further expand the use of the
technology for a range of tissue defects. The technology, which is
based on a modular platform combining FDA approved materials,
is poised for translation from the lab bench to the surgical patient.
Supporting Information
Figure S1 Sixteen weeks after surgery. High resolution micro-
computed tomography (m-CT) images from the five femora
making up the Control group, which was treated with an isotropic
surgical membrane. Infilling occurs mainly through axial osteo-
conduction from proximal and distal edges toward the center of
the defect zone.
(TIFF)
Figure S2 A. Three weeks after surgery. High resolution micro-
computed tomography (m-CT) images from the five femora
making up Group 1, which was treated with the directional
delivery membrane incorporating collagen sheets. Infilling occurs
mainly radially, via inward intramembranous bone formation,
from the inner surface of the surgical membrane towards the outer
surface of the intramedullary nail. B. Sixteen weeks after surgery.
High resolution micro-computed tomography (m-CT) images from
the five femora making up Group 1 of the current study, which
was treated with the directional delivery membrane incorporating
collagen sheets. Radial intramembranous bone formation ob-
served at three weeks is no longer evident. Small amounts of
infilling occur via axial osteoconduction from proximal and distal
edges of the defect zone.
(TIFF)
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directional delivery membrane incorporating collagen sheets
seeded with autogenous periosteum-derived cells. High resolution
micro-computed tomography (m-CT) images of the femoral defect
zones in the five femora making up Group 2. Infilling occurs
radially via osteoinduction and axially via osteoconduction. Best
infilling is observed in cases where the two coalesce.
(TIFF)
Figure S4 Sixteen weeks after the two stage surgery with a
directional delivery membrane incorporating strips of autogenous
periosteum from the bone removed to create the defect. High
resolution micro-computed tomography (m-CT) images of the
femoral defect zones in the five femora making up Group 3.
Infilling occurs radially via osteoinduction and axially via
osteoconduction. Best infilling is observed in cases where the two
coalesce.
(TIFF)
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